Anpac Bio-Medical Science Co., Ltd. to Present at National Investment Banking Association (NIBA) Conference
Anpac Bio is a biotechnology company focusing on early cancer screening and detection, as well as marketing a suite of cancer detection tests, including Cancer Differentiation Analysis (CDA), bio-chemistry, immunology and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented CDA technology and proprietary cancer-detection device. For more information, visit the company's website at www.anpacbio.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and…







